E. Dansin
Oncologie, Vol.21, No.2, pp. 83-89, 2019, DOI:10.3166/onco-2019-0047
Abstract Typical or atypical bronchial carcinoids are rare
tumors. The management of localized forms is essentially
based on surgery and their prognosis remains good. The
treatment of metastatic forms remains difficult with a low
level of evidence. New treatments are emerging (everolimus,
Lutatherapy), however, their respective place in the therapeutic algorithm should be clarified. Access to expertise
and clinical research via the RENATEN-TENpath network
should be promoted.
Résumé
Les carcinoïdes bronchiques typiques ou atypiques
sont des tumeurs rares. La prise en charge des formes localisées repose essentiellement sur la chirurgie, et leur pronostic
reste bon. Le traitement des formes métastatiques demeure
difficile et… More >